ipamorelin clinical trials safety cjc-1295 ipamorelin clinical trial growth hormone secretagogue safety How different peptide therapies may affect your body ipamorelin clinical trials safety adverse

Peptide Vials (GHK-Cu, 100 mg each): 5 days/week (1.0-2.0 mg/day): 8 weeks (~50 mg total): 1 vial 12 weeks (~90 mg total): 1 vial 16 weeks (~130 mg total): 2 vials 3 times/week (2 mg each): 8 weeks (~48 mg total): 1 vial 12 weeks (~72 mg total): 1 vial 16 weeks (~96 mg total): 1 vial Insulin Syringes (U-100, 29-31 gauge): 5 days/week: Per week: 5 syringes 8 weeks: 40 syringes 12 weeks: 60 syringes 16 weeks: 80 syringes 3 times/week: Per week: 3 syringes 8 weeks: 24 syringes 12 weeks: 36 syringes 16 weeks: 48 syringes Sterile or Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for the displayed calculation

I ordered more syringes and will be doing another 30 days

10.1093/oxfordjournals.humrep.a135772 31

Animal studies demonstrate reduced lipid peroxidation in retinal tissue

BPC-157 (Body Protection Compound-157) is a synthetic peptide made of 15 amino acids (a pentadecapeptide) derived from a protective protein naturally found in gastric juice and the stomach lining